Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: Applications in diagnostic imaging and therapy

Authors

Hiroyuki Kashiwagi, Washington University School of Medicine in St. LouisFollow
Jonathan E. McDunn, Washington University School of Medicine in St. Louis
Peter O. Simon Jr, Washington University School of Medicine in St. Louis
Peter S. Goedegebuure, Washington University School of Medicine in St. LouisFollow
Jinbin Xu, Washington University School of Medicine in St. Louis
Lynne Jones, Washington University School of Medicine in St. Louis
Katherine Chang, Washington University School of Medicine in St. LouisFollow
Fabian Johnston, Washington University School of Medicine in St. Louis
Kathryn Trinkaus, Washington University School of Medicine in St. Louis
Richard S. Hotchkiss, Washington University School of Medicine in St. LouisFollow
Robert H. Mach, Washington University School of Medicine in St. LouisFollow
William G. Hawkins, Washington University School of Medicine in St. LouisFollow

Journal

Molecular Cancer

Publication Date

2007

Volume

6

Inclusive Pages

48

Document Type

Open Access Publication

Rights and Permissions

Molecular Cancer 2007, 6:48 http://www.molecular-cancer.com/content/6/1/48 © 2007 Kashiwagi et al; licensee BioMed Central Ltd.

Recommended Citation

Kashiwagi, Hiroyuki; McDunn, Jonathan E.; Simon, Peter O. Jr; Goedegebuure, Peter S.; Xu, Jinbin; Jones, Lynne; Chang, Katherine; Johnston, Fabian; Trinkaus, Kathryn; Hotchkiss, Richard S.; Mach, Robert H.; and Hawkins, William G., "Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: Applications in diagnostic imaging and therapy." Molecular Cancer. 6, 48. (2007).
https://digitalcommons.wustl.edu/open_access_pubs/206